Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial

Clinical trial NCT03431142 · COMPLETED

Trial details

NCT number: NCT03431142
Sponsor: Shenyang Northern Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage

Start date: 2018-02-12
Primary completion: 2020-12-30
Enrollment: 7758

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.